Friday December 14, 2018 06:09

Heathcare Press Release : 02 Jun 2016

Occlutech Obtains European CE Mark Approval for its LAA Occluder Heathcare—02 Jun 16

Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Left Atrial Appendix, (LAA), occluder. The device is a specifically designed implant for the minimally